Odelia Cooper MD
Adrenal Disease, Pituitary Disorders & Neuroendocrinology
Professor of Medicine, Endocrinology, Cedars-Sinai Medical Center
Join to view full profile
127 S. Vicente BlvdA6600Los Angeles, CA 90048
Phone+1 310-423-2830
Fax+1 310-423-2819
Dr. Cooper is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Cedars-Sinai Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2006 - 2008- Cedars-Sinai Medical CenterResidency, Internal Medicine, 2003 - 2006
Johns Hopkins University School of MedicineClass of 2002
Certifications & Licensure
CA State Medical License 2004 - 2028
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Sunquest Laboratory, Sunquest Information Systems, Inc., 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite (with Beaker), Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- Correction: Long-term cabergoline use does not predict degree of prolactinoma fibrosis nor significantly impact surgical outcomes.Adam N Mamelak, Rachel Fox, Yaakov Rosenberg, Daniel Gomez, Yujie Cui
Pituitary. 2026-08-23 - 4 citationsLong-term cabergoline use does not predict degree of prolactinoma fibrosis nor significantly impact surgical outcomes.Adam N Mamelak, Rachel Fox, Yaakov Rosenberg, Daniel Gomez, Yujie Cui
Pituitary. 2026-01-12 - 11 citationsImmune Checkpoint Inhibitor Therapy for Aggressive Pituitary Neuroendocrine Tumors.Andrew L Lin, Vasilisa Rudneva, Adam Newton, Nazanin K Majd, Rajiv Magge
The Journal of Clinical Endocrinology and Metabolism. 2025-10-16
Press Mentions
‘Promising’ New Data Could Change Treatment Landscape for Some Rare DiseasesSeptember 16th, 2025- Endocrinology, Diabetes and Metabolism Board Meeting Summary | Spring 2025June 4th, 2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: